Baird raises target for Cencora stock to USD 373.00
Published on 10/15/2026 at 10:17 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWSAnalyst action and results
- Robert W. Baird lifted its Cencora target to USD 373.00 on October 12, 2026.
- Fiscal third-quarter revenue reached USD 84.75 billion, up 5.10 percent year over year.
- Cencora stock traded at EUR 303.00 at 10:07 a.m. CEST at Lang & Schwarz on October 15, 2026.
Cencora stock traded at EUR 303.00 at Lang & Schwarz on October 15, 2026. The latest analyst catalyst came from Robert W. Baird, which raised its target from USD 370.00 to USD 373.00 while maintaining an Outperform rating, according to MarketBeat on October 12, 2026.
Results support the target
Cencora reported fiscal third-quarter revenue of USD 84.75 billion for the period ended June 30, 2026, an increase of 5.10 percent from the prior-year quarter. Adjusted earnings per share reached USD 4.48, exceeding the USD 4.35 consensus estimate, while GAAP diluted earnings per share stood at USD 3.94. These figures were reported by Business Wire.
Management also lifted fiscal 2026 adjusted earnings-per-share guidance to USD 17.75-17.95 from USD 17.70-17.90. The updated range followed adjusted operating income growth of 17 percent in the fiscal third quarter, according to Benzinga on October 8, 2026.
Three dates frame the story
On August 5, 2026, Cencora reported USD 84.75 billion in fiscal third-quarter revenue and USD 4.48 in adjusted earnings per share. On September 25, 2026, the company announced a board appointment while describing annual revenue above USD 300 billion in its release. On October 12, 2026, Robert W. Baird raised its target by USD 3.00 to USD 373.00, the most recent event in this sequence.
What does the target mean?
The target change is modest in absolute terms, but it confirms that Baird kept its Outperform view while moving the valuation reference from USD 370.00 to USD 373.00. MarketBeat also listed 14 Buy ratings and four Holds, alongside an average target of USD 365.69 on October 12, 2026. The main counterweight is valuation: the same source cited a fifty-two-week high of USD 377.54 and a price-to-earnings ratio of 24.16.
Next reporting date
Cencora plans to release fiscal fourth-quarter 2026 results before the New York Stock Exchange opens on November 4, 2026, with an earnings call at 8:30 a.m. ET. The date was announced by Cencora on October 2, 2026.
Stock price and valuation
Cencora stock was trading at EUR 303.00 at Lang & Schwarz on October 15, 2026 at 10:07 a.m. CEST. Its primary listing is on the NYSE, where the October 12, 2026 market capitalization was USD 62.1 billion and the fifty-two-week range was USD 244.82 to USD 377.54. The further course of trading is shown by the continuously updated real-time quote of Cencora stock.
Cencora stock facts
- Company: Cencora, Inc.
- ISIN: US03073E1055
- Ticker: COR
- Primary exchange: NYSE
- Price Lang & Schwarz (as of October 15, 2026, 10:07 a.m. CEST): EUR 303.00
- Market capitalization: USD 62.1 billion (as of October 12, 2026)
- 52-week range: USD 244.82-377.54 (as of October 12, 2026)
- Sector / Industry: Healthcare / Medical Distribution
Market context: Market report S&P 500.
